- Danish stocks
- Norwegian stocks
- Swedish stocks
- AktieTorget
- A1M Pharma
- Accelerator Nordic
- AlphaHelix
- AroCell
- Biotech-IgG
- Brighter
- Clinical Laserthermia
- Emotra
- Enzymtica
- Eurocine Vaccines
- European Inst. of Science
- IDL Biotech
- Medfield Diagnostics
- MedicPen
- MediRox
- MediRätt
- Micropos Medical
- PharmaLundensis
- Respiratorius
- Rubicon Life Science
- SensoDetect
- WntResearch
- Orasolv
- Senzime
- SPAGO Imaging
- Vivoline Medical
- First North Stockholm
- OMX Stockholm A-F
- OMX Stockholm G-Z
- AktieTorget
- US stocks
- General discussion
- All posts
In this section we will try to have the most recent links. At this point of time new surveys are published almost on a daily basis. We cannot promise to include all relevant links – but will try to do our best.. Some we will comment – others you have to digest for yourself 😉
NGAL is very much the talk of the town – AND not only as a marker for AKI.
http://www.youtube.com/watch?feature=player_embedded&v=HCLYK45LjbY
A fantastic new study comparing NGAL to the Troponin revolution.
Dr Kai Schmidt-Ott from Schweiz on the newest survey – bye bye Serum Creatinine
In german : NGAL is better and cheaper than serum creatinine.
Measure of five urinary biomarkers from almost 1700 emergency room patients.
Interesting – a third of all bypass-patients develop AKI.
Conclusion: NGAL is an interesting marker.
Bioporto’s response to the opposition division of EPO.
the strenght of NGAL in prediction of AKI
The new Gold standard?
NGAL has been shown to be useful in the diagnosis of AKI.
Insights on urinary NGAL obtained in a primary care setting
NGAL is the better marker for use in emergency rooms.
NGAL and other markers in connection with Cronic Kidney disease.
NGAL – no measurable difference between blast and gunshot injury
NGAL may identify patients at risk for organ injury, allow earlier intervention and reduce cost
A comprehensive internet guide to nephrology – LOADS of info
41 minuts of Abbott presentation on Urin NGAL, presented by Claudio Ronco. (will only play in Internet Explorer)
http://www.academypublish.org/papers/pdf/869.pdf
Ongoing debate
- Lesliejek on Chat transcript regarding the NGAL distr. Agreement with the Wiener Group. (In danish)
- Patrickciz on Chat transcript regarding the NGAL distr. Agreement with the Wiener Group. (In danish)
- Jameskipse on Chat transcript regarding the NGAL distr. Agreement with the Wiener Group. (In danish)
- Rickiehiela on Chat transcript regarding the NGAL distr. Agreement with the Wiener Group. (In danish)
- James Rolitson on Good Discussion on Bronte Capital’s long thesis on Herbalife